FINN THERAPEUTICS LTD

Active Belfast
2 employees website.com
Life sciences and medical technology
F

FINN THERAPEUTICS LTD

Founded 2 Sept 2020 Active Belfast, Northern Ireland 2 employees website.com
Life sciences and medical technology

Previous Company Names

FINN THERAPEUTIC LIMITED 2 Sept 2020 — 7 Sept 2021
Accounts Submitted 16 Apr 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 6 May 2026 Next due 4 Mar 2027 8 months remaining
Net assets £-19K £28K 2025 year on year
Total assets £39K £5K 2025 year on year
Total Liabilities £59K £23K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Glendinning House 6 Murray Street Belfast BT1 6DN Northern Ireland

Website

www.example.com

Full company profile for FINN THERAPEUTICS LTD (NI672275), an active life sciences and medical technology company based in Belfast, Northern Ireland. Incorporated 2 Sept 2020. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type micro-entity
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2025)

Cash in Bank

N/A

Decreased by £29.00 (-100%)

Net Assets

-£19.47k

Decreased by £28.43k (-317%)

Total Liabilities

£58.69k

Increased by £23.29k (+66%)

Turnover

N/A

Employees

2

Debt Ratio

150%

Increased by 70 (+88%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Dec Year End
2024
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 1,159,990 Shares £116k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
17 Feb 202560,000£6k£0.1
27 Aug 20211,099,990£110k£0.1

Officers

Officers

1 active 2 resigned
Status
Kerr, Paul Gerard, DrDirectorBritishNorthern Ireland5427 Aug 2021Active

Shareholders

Shareholders (20)

Paul Kerr
14.4%
150,000
Caroline Keenan
14.4%
150,000

Persons with Significant Control

Persons with Significant Control (3)

3 Active

Christophe Pierre Maurice Mazars

French

Active
Notified 2 Sept 2020
Residence France
DOB March 1971
Nature of Control
  • Significant Influence Or Control

Paul Gerard Kerr

British

Active
Notified 27 Aug 2021
Residence Northern Ireland
DOB February 1972
Nature of Control
  • Significant Influence Or Control

Dr Paul Gerard Kerr

British

Active
Notified 27 Aug 2021
Residence Northern Ireland
DOB February 1972
Nature of Control
  • Significant Influence Or Control

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Jun 2026IncorporationMemorandum Articles
3 Jun 2026IncorporationMemorandum Articles
1 Jun 2026OfficersAppointment of Dr Anthony Arthur O'kane as director on 20 May 2026
29 May 2026ResolutionResolutions
16 May 2026CapitalCapital Statement Capital Company With Date Currency Figure
3 Jun 2026 Incorporation

Memorandum Articles

3 Jun 2026 Incorporation

Memorandum Articles

1 Jun 2026 Officers

Appointment of Dr Anthony Arthur O'kane as director on 20 May 2026

29 May 2026 Resolution

Resolutions

16 May 2026 Capital

Capital Statement Capital Company With Date Currency Figure

Recent Activity

Latest Activity

Memorandum Articles

1 weeks ago on 3 Jun 2026

Memorandum Articles

1 weeks ago on 3 Jun 2026

Appointment of Dr Anthony Arthur O'kane as director on 20 May 2026

1 weeks ago on 1 Jun 2026

Resolutions

1 weeks ago on 29 May 2026

Capital Statement Capital Company With Date Currency Figure

3 weeks ago on 16 May 2026